KO-2806

· Kura Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KO-2806, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors [Phase 1]